Published in Obstet Gynecol on October 01, 1992
A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol (2010) 1.70
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis (2001) 1.41
The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis (2005) 1.17
Thrombophilia and pregnancy. Reprod Biol Endocrinol (2003) 1.16
Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis (2002) 1.13
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta (2010) 1.08
Antiphospholipid syndrome: an overview. CMAJ (2003) 1.05
Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med (2011) 1.02
Pregnancy in systemic lupus erythematosus. Postgrad Med J (2001) 0.97
Stroke in pregnancy and the puerperium: what magnitude of risk? J Neurol Neurosurg Psychiatry (1995) 0.96
Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth (2009) 0.82
Association of inherited thrombophilia with recurrent pregnancy loss in palestinian women. Obstet Gynecol Int (2011) 0.81
Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications. Clin Dev Immunol (2013) 0.80
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J Clin Invest (2016) 0.80
Hereditary thrombophilic risk factors for recurrent pregnancy loss. J Community Genet (2010) 0.79
Low molecular weight heparin in immunological recurrent abortion--the incredible cure. J Assist Reprod Genet (2003) 0.79
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. BMC Res Notes (2014) 0.76
Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. Clin Rev Allergy Immunol (2017) 0.76
Systemic lupus erythematosus: strategies to improve pregnancy outcomes. Int J Womens Health (2016) 0.75
Antiphospholipid syndrome. J R Soc Med (2002) 0.75
A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism. Obstet Med (2009) 0.75
Fluctuation in the Levels of Immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and β2-Glycoprotein among Healthy Pregnant Women. Sultan Qaboos Univ Med J (2014) 0.75
Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects. Infect Dis Obstet Gynecol (1997) 0.75
Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol (1991) 4.99
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol (1993) 3.76
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Phage Pl cryptic. II. Location and regulation of prophage genes. Virology (1973) 3.63
Regulation of plasmid replication. Microbiol Rev (1984) 3.55
Optimal management strategies for placenta accreta. BJOG (2009) 3.51
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
Genetic manipulation of pathogenic streptococci. Methods Enzymol (1991) 3.34
Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
Excision and insertion of the conjugative transposon Tn916 involves a novel recombination mechanism. Cell (1989) 2.91
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis (2009) 2.76
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
A plasmid-encoded regulatory gene, rns, required for expression of the CS1 and CS2 adhesins of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.62
Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57
A turbid plaque-forming mutant of phage P1 that cannot lysogenize Escherichia coli. Virology (1974) 2.47
TUBERCULOSIS OF THE APPENDIX. Ann Surg (1917) 2.44
Genetic studies on bacteriophage P1. Virology (1968) 2.43
A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med (1999) 2.33
Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Is vaginal birth after cesarean less expensive than repeat cesarean delivery? Am J Obstet Gynecol (2000) 2.09
Scleroderma following augmentation mammoplasty. Report of a case and review of the literature. Arch Dermatol (1990) 2.08
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Obstetric complications associated with the lupus anticoagulant. N Engl J Med (1985) 2.05
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA (1995) 2.02
Pharmaceutical history and its sources in the Wellcome collections. 3. Fluid medicines, prescription reform and posology 1700-1900. Med Hist (1970) 2.01
Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol (1998) 1.96
Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect Immun (1995) 1.95
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
Integration of the plasmid prophages P1 and P7 into the chromosome of Escherichia coli. J Mol Biol (1979) 1.83
Effect of psychoprophylaxis (Lamaze preparation) on labor and delivery in primiparas. N Engl J Med (1976) 1.80
Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78
Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol (1995) 1.70
Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun (1997) 1.68
Conformational characteristics of the complete sequence of group A streptococcal M6 protein. Proteins (1988) 1.62
Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1992) 1.62
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Risk factors for postoperative pneumonia. Am J Med (1981) 1.62
Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr (2000) 1.61
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med (1993) 1.61
A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect Immun (1989) 1.58
Acquisition of iron from host proteins by the group A streptococcus. Infect Immun (1996) 1.54
Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli. Infect Immun (1990) 1.53
Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem (2001) 1.52
Introduction of the emm6 gene into an emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res Microbiol (1993) 1.48
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum (1989) 1.47
Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum (1984) 1.46
Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol (1995) 1.46
Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun (2000) 1.45
Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum (1998) 1.45
Preliminary evidence for homoeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet (1991) 1.42
A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40
Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1983) 1.39
Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol (1995) 1.38
Rns, a virulence regulator within the AraC family, requires binding sites upstream and downstream of its own promoter to function as an activator. Mol Microbiol (2000) 1.38
Privacy and publication. Obstet Gynecol (2001) 1.38
Major flame burn caused by electric fly-swatter. J Burns Wounds (2007) 1.38
A rns-like regulatory gene for colonization factor antigen I (CFA/I) that controls expression of CFA/I pilin. Infect Immun (1990) 1.37
Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun (2001) 1.34
CooC and CooD are required for assembly of CS1 pili. Mol Microbiol (1994) 1.32
Photosynthetic carbon metabolism of a marine grass. Plant Physiol (1976) 1.31
New tools in an old trade: CS1 pilus morphogenesis. Mol Microbiol (1998) 1.30
Regulation of rns, a positive regulatory factor for pili of enterotoxigenic Escherichia coli. J Bacteriol (1994) 1.29
Clear plaque mutants of phage P1. Virology (1970) 1.28
The presence of conjugative transposon Tn916 in the recipient strain does not impede transfer of a second copy of the element. J Bacteriol (1991) 1.28
Role of the conserved C-repeat region of the M protein of Streptococcus pyogenes. Mol Microbiol (1995) 1.28
Binding site recognition by Rns, a virulence regulator in the AraC family. J Bacteriol (1999) 1.27
Streptococcal M protein size mutants occur at high frequency within a single strain. J Exp Med (1986) 1.25
Assembly proteins of CS1 pili of enterotoxigenic Escherichia coli. Mol Microbiol (1996) 1.25
A secondary RNA polymerase sigma factor from Streptococcus pyogenes. Mol Microbiol (2001) 1.24
Regulation of mga transcription in the group A streptococcus: specific binding of mga within its own promoter and evidence for a negative regulator. J Bacteriol (1999) 1.23
Regulation of excision of the conjugative transposon Tn916. Mol Microbiol (1999) 1.22
A new gene controlling lysogeny in phage P1. Virology (1972) 1.20
Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ Health Perspect (1977) 1.19
Identification of isp, a locus encoding an immunogenic secreted protein conserved among group A streptococci. Infect Immun (1996) 1.19
Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology (1990) 1.18
Excision of a conjugative transposon in vitro by the Int and Xis proteins of Tn916. Nucleic Acids Res (1997) 1.18
DNA binding by the Xis protein of the conjugative transposon Tn916. J Bacteriol (1997) 1.18
Relationships between temperate phages Mu and P1. Virology (1978) 1.17
Conjugative transposition of Tn916: the transposon int gene is required only in the donor. J Bacteriol (1992) 1.17
Isolation and characterization of cloned fragments of bacteriophage P1 DNA. Virology (1979) 1.17
Novel group of virulence activators within the AraC family that are not restricted to upstream binding sites. Infect Immun (2001) 1.16
Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res (1994) 1.16
Iron starvation causes release from the group A streptococcus of the ADP-ribosylating protein called plasmin receptor or surface glyceraldehyde-3-phosphate-dehydrogenase. Infect Immun (1996) 1.15
High resolution computed tomography in early scleroderma lung disease. J Rheumatol (1991) 1.14
A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol (2000) 1.14
Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol (1994) 1.14
Association of rns homologs with colonization factor antigens in clinical Escherichia coli isolates. Infect Immun (1990) 1.14
Histoincompatibility and maternal immunological status as determinants of fetoplacental weight and litter size in rodents. J Exp Med (1975) 1.13
Antiplatelet antibodies and platelet counts in pregnancies complicated by autoimmune thrombocytopenic purpura. Am J Obstet Gynecol (1983) 1.13
Structure, function, and genetics of streptococcal M protein. Rev Infect Dis (1988) 1.13
The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol (1989) 1.12